Prof. Dr. İrfan Çiçin

Need for Patient Education and Better Physician-Patient Communication in Melanoma Patients

Türkderm Türk Deri Hastalıkları ve Frengi Arşivi, 2021

Kaynak: YÖK Akademik

PROGNOSTIC AND PREDICTIVE MARKERS OF FOLFIRI/AFLIBERCEPT IN PATIENTS WITH METASTATIC COLORECTAL CANCER (TOG STUDY)

AYBU AVESIS, 2020

Kaynak: OpenAlex

GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients

Lung Cancer, 2020

DOI 10.1016/j.lungcan.2020.07.022 PMID 32799090 30 atıf (Europe PMC) Kaynak: OpenAlex

Retrospective analysis of ribociclib and letrozole as first-line therapy in patients with hormone receptor (HR) positive metastatic breast cancer (MBC) within a managed access program (MAP) in Turkey.

Journal of Clinical Oncology, 2020

DOI 10.1200/jco.2020.38.15_suppl.e13055 Kaynak: OpenAlex

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

Journal of Clinical Oncology, 2020

DOI 10.1200/jco.20.02514 PMID 32954927 837 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

The Lancet Oncology, 2020

DOI 10.1016/s1470-2045(20)30539-8 PMID 33285097 584 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407

Journal of Thoracic Oncology, 2020

DOI 10.1016/j.jtho.2020.06.015 PMID 32599071 504 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study

ESMO Open, 2020

DOI 10.1136/esmoopen-2020-000698 PMID 32487542 30 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)

Journal of Oncology Pharmacy Practice, 2020

DOI 10.1177/1078155219900908 PMID 32054412 9 atıf (Europe PMC) Kaynak: OpenAlex

Turkish national consensus on breast cancer management during temporary state of emergency due to COVID-19 outbreak

Turkish Journal of Surgery, 2020

DOI 10.5578/turkjsurg.4815 PMID 33015560 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Clinicopathological and prognostic characteristics of acral metastases in patients with malignant disease: A retrospective study

Acta Orthopaedica et Traumatologica Turcica, 2020

DOI 10.5152/j.aott.2020.20052 PMID 33650515 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Genetic screening results of individuals with high risk BRCA-related breast/ovarian cancer in Trakya region of Turkey.

PubMed, 2020

PMID 32862574 6 atıf (Europe PMC) Kaynak: OpenAlex

Relationship between the Size and Location of the Mass and Hilar and Mediastinal Lymph Node Metastasis in Early and Locally Advanced Non-small Cell Lung Cancer

Journal of College of Physicians And Surgeons Pakistan, 2020

DOI 10.29271/jcpsp.2020.02.172 PMID 32036826 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

The relationship between FDG PET/CT-defined metabolic parameters and the histopathological subtype of oesophageal carcinomas

Polish Journal of Radiology, 2020

DOI 10.5114/pjr.2020.95945 PMID 32612724 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Prognostic Effect of Albumin-Bilirubin Grade on Survival in Advance Gastric Cancer Patients with de-novo Liver Metastasis

Journal of Oncological Sciences, 2020

DOI 10.37047/jos.2020-77649 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Contrast nephropathy in cancer patients receiving anti-VEGF therapy: a prospective study

International Journal of Clinical Oncology, 2020

DOI 10.1007/s10147-020-01729-3 PMID 32591963 3 atıf (Europe PMC) Kaynak: OpenAlex

Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey.

PubMed, 2020

PMID 33099930 5 atıf (Europe PMC) Kaynak: OpenAlex

Targeted next-generation sequencing as a diagnostic tool in gastrointestinal system cancer/polyposis patients

Tumori Journal, 2020

DOI 10.1177/0300891620919171 PMID 32390558 2 atıf (Europe PMC) Kaynak: OpenAlex

Third-line Therapy for Metastatic Renal Cell Carcinoma and Its Effect on Quality of Life and Overall Survival: A National, Multicenter, Observational Study

Journal of Oncological Sciences, 2020

DOI 10.37047/jos.2020-75080 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Stage I colon cancer that spreads into a colovesical fistula-mediated bladder due to crohn's disease: A case report

Current Problems in Cancer Case Reports, 2020

DOI 10.1016/j.cpccr.2020.100010 Açık erişimli tam metinKaynak: OpenAlex

Phase II trial of SAR439859 vs endocrine monotherapy in pre- and post-menopausal, estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-), locally advanced or metastatic breast cancer (BC) with prior exposure to hormonal therapies.

Journal of Clinical Oncology, 2020

DOI 10.1200/jco.2020.38.15_suppl.tps1107 Kaynak: OpenAlex

Pandemi Döneminde Kanser Klinik Araştırmaları

Türkiye Klinikleri COVID - 19, 2020

Kaynak: OpenAlex

Gastrointestinal Tümörlerde Nütrisyonel Tedavi

Turkiye Klinikleri Medical Oncology - Special Topics, 2020

Kaynak: OpenAlex

Optimal Cytoreduction is an Independent Prognostic Factor in Ovarian Carcinosarcoma: A Turkish Gynecologic Oncology Group Study

Journal of Oncological Sciences, 2020

DOI 10.37047/jos.2019-73073 Açık erişimli tam metinKaynak: OpenAlex

Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study

Journal of Oncology Pharmacy Practice, 2020

DOI 10.1177/1078155220963535 PMID 33050804 Kaynak: OpenAlex

Comparison of Neoadjuvant Chemotherapy and Bladder-Preserving Chemoradiation in Patients with Non-Metastatic, Muscle-Invasive Bladder Cancer: A Single-Center Experience

Journal of Oncological Sciences, 2020

DOI 10.37047/jos.2020-77532 Açık erişimli tam metinKaynak: OpenAlex

Yaşlı Kanser Hastalarında İmmünoterapi

Turkiye Klinikleri Medical Oncology - Special Topics, 2020

Kaynak: OpenAlex

Multicenter real life expeMulticenter real life experience of biological agents in patients with metastatic colorectal cancerrience of biological agents in patients with metastatic colorectal cancer

2020

Kaynak: OpenAlex

Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey

Bursa Uludag University - AVESIS, 2020

Kaynak: OpenAlex

PROGNOSTIC AND PREDICTIVE MARKERSOF FOLFIRI/AFLIBERCEPT IN PATIENTS WITHMETASTATIC COLORECTAL CANCER (TOG STUDY)Cihan Erol1, Mutlu Hızal2, Irem Bilgetekin3, Sinem Akbas4,Duygu Bayir Garbioglu5, Jamshid Hamdard6, Cagatay Arslan7,Alper Sevinc8, Ahmet Kucukarda9, Dilek Gurgenyatagi10, EmreCakir11, Aykut Demirkiran12, Murat Araz12, Sercan On13, IzzetDogan14, Atike Pinar Erdogan15, Sinan Koca16, Pinar Kubilay17,Onder Eren18, Deniz Tataroglu Ozyukseler19, Mahmut EmreYildirim19, Ebru Cilbir20, Emir Celik21, Aykut Bahceci22, HalilTaskaynatan23, Abdulkerim Oyman24, Gulhan Ipek Deniz25,Serkan Menenekse26, Engin Kut26, Ahmet Gulmez27, AbdullahSakin28, Erdinc Nayir29, Ramazan Acar30, Seda Kahraman1,Erdem Sen31, Ali Inal32, Serdar Turhal33, Ali Osman Kaya34, SemraPaydas35, Didem Tastekin14, Ilhan Hacıbekiroglu11, Irfan Cicin9,Ahmet Bilici6, Didem Sener Dede1, Muhammed Bulent Akinci1,Nil Molinas Mandel36, Berna Oksuzoglu3, Dogan Uncu2, BulentYalcin1, Mehmet Artac12, Mehmet Ali Nahit Sendur1

AYBU AVESIS, 2020

Kaynak: OpenAlex

IMMUNOTHERAPY IN ELDERLY CANCER PATIENTS

Turkiye Klinikleri eBooks, 2020

DOI 10.5336/978-625-401-191-7_p106 Kaynak: OpenAlex

Phase II trial of SAR439859 vs endocrine monotherapy in pre- and post-menopausal, estrogen receptor-positive (ER plus )/human epidermal growth factor receptor 2-negative (HER2-), locally advanced or metastatic breast cancer (BC) with prior exposure to hormonal therapies.

Trakya University's Institutional Open Access System (Trakya University), 2020

Kaynak: OpenAlex

Evaluating sun protection behaviors and skin self‐examination practices among the family members of melanoma patients in Turkey: A cross‐sectional survey study

Dermatologic Therapy, 2020

DOI 10.1111/dth.14268 PMID 32882080 6 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Targeted next-generation sequencing as a diagnostic tool in gastrointestinal system cancer/polyposis

Tumori Journal, 2020

Kaynak: YÖK Akademik

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Annals of Oncology, 2019

DOI 10.1093/annonc/mdz061 PMID 30796821 87 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial

The Lancet Oncology, 2019

DOI 10.1016/s1470-2045(19)30668-0 PMID 31753727 70 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non–Small-Cell Lung Cancer

Journal of Clinical Oncology, 2019

DOI 10.1200/jco.19.01348 PMID 31751163 79 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer

Journal of Oncology Pharmacy Practice, 2019

DOI 10.1177/1078155219883004 PMID 31653193 17 atıf (Europe PMC) Kaynak: OpenAlex

Concordance of PD-L1 expression and CD8+ TIL intensity between NSCLC and synchronous brain metastases

Bosnian Journal of Basic Medical Sciences, 2019

DOI 10.17305/bjbms.2019.4474 PMID 31999935 21 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

Clinical Colorectal Cancer, 2019

DOI 10.1016/j.clcc.2019.05.003 PMID 31221542 14 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer

Cancer Chemotherapy and Pharmacology, 2019

DOI 10.1007/s00280-019-03779-5 PMID 30680522 8 atıf (Europe PMC) Kaynak: OpenAlex

Comparison of skeletal muscle mass loss in patients with metastatic colorectal cancer treated with regorafenib or TAS-102.

PubMed, 2019

PMID 31786894 7 atıf (Europe PMC) Kaynak: OpenAlex

Prognostic factors and oncological outcomes of ovarian yolk sac tumors: a retrospective multicentric analysis of 99 cases

Archives of Gynecology and Obstetrics, 2019

DOI 10.1007/s00404-019-05160-6 PMID 30982145 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Is the Charlson Comorbidity Index a Prognostic Indicator for Toxicity and Mortality in Elderly Patients with Locally Advanced Rectal Cancer?

PubMed, 2019

PMID 31256595 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

The albumin-bilirubin (ALBI) grade as a significant prognostic factor in colorectal cancer patients with liver metastases

Journal of Surgery and Medicine, 2019

DOI 10.28982/josam.597751 3 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Association of adverse events (AEs) with efficacy outcomes for cabozantinib (C) in patients (pts) with advanced hepatocellular carcinoma (aHCC) in the phase III CELESTIAL trial.

Journal of Clinical Oncology, 2019

DOI 10.1200/jco.2019.37.15_suppl.4088 23 atıf (OpenAlex) Kaynak: OpenAlex

Trifluridine/tipiracil (FTD/TPI) in patients (pts) aged ≥65 years with metastatic gastric/gastroesophageal junction cancer (mGC/mGEJC): Subgroup analysis from TAGS.

Journal of Clinical Oncology, 2019

DOI 10.1200/jco.2019.37.15_suppl.4037 8 atıf (OpenAlex) Kaynak: OpenAlex

Pregnancy and Gastrointestinal Cancers

Springer eBooks, 2019

DOI 10.1007/978-3-030-18890-0_36 Kaynak: OpenAlex

Effect of clinical and pathological features of gastrointestinal stromal tumors on overall survival and prognosis: Single center experience

Journal of Oncological Sciences, 2019

DOI 10.1016/j.jons.2019.10.003 Açık erişimli tam metinKaynak: OpenAlex

Bone-Directed Therapy and Breast Cancer: Bisphosphonates, Monoclonal Antibodies, and Radionuclides

Springer eBooks, 2019

DOI 10.1007/978-3-030-16792-9_42 Kaynak: OpenAlex